课题基金 / 基金详情

项目摘要

项目成果

Peter Leif Bergsagel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT The overall goal of the Mayo Clinic Multiple Myeloma SPORE (SPORE) Administration Core is to stimulate research in myeloma and to expedite the translation of discoveries into new and better methods of prevention, detection, and treatment of myeloma. The Administration Core has served well as the organizational hub of SPORE during the prior funding period. During the next grant period, it will continue to provide an organizational structure designed to coordinate the activities of the research projects, scientific cores, and developmental programs (Developmental Research Program, Career Enhancement Program). The Administration Core will be responsible for coordinating the function of the SPORE committees including the Executive Committee, the External Advisory Committee, and the Patient Advocate Group. Drs. Leif Bergsagel and Vincent Rajkumar will serve as Co-Directors of the Administration Core. Bergsagel and Rajkumar functioned well as a team during the prior funding period, and will continue to work collaboratively to provide oversight of SPORE activities. The Administration Core will: 1) Provide leadership, organizational support, and financial management for SPORE investigators 2) Coordinate communication and collaboration between Mayo Clinic Arizona, Rochester and Florida, including support for exchange of ideas between investigators, design of new projects, conduct of translational research, and reporting of translational research findings 3) Provide information transfer to the scientific community and the public 4) Provide leadership and organizational support for interactions with the External Advisory Committee, as well as external and internal review for SPORE research projects 5) Provide the structure for the establishment and nurture of collaborations to facilitate and expand myeloma research including interactions between Mayo sites 6) Work closely with SPORE patient advocates so that they are aware of the progress of the SPORE, and facilitate their ability to provide input at all levels 7) Foster young investigator development 8) Communicate with the NCI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
preclinical optimization of BCMA directed T cell therapy
  • 批准号:
    10802050
  • 项目类别:
  • 资助金额:
    $62.19万
  • 财政年份:
    2023
  • 负责人:
    Peter Leif Bergsagel
  • 依托单位:
Admin Core
  • 批准号:
    10006207
  • 项目类别:
  • 资助金额:
    $8.37万
  • 财政年份:
    2020
  • 负责人:
    Peter Leif Bergsagel
  • 依托单位:
Admin Core
  • 批准号:
    10494370
  • 项目类别:
  • 资助金额:
    $8.33万
  • 财政年份:
    2017
  • 负责人:
    Peter Leif Bergsagel
  • 依托单位:
Overcoming Drug Resistance in Multiple Myeloma
  • 批准号:
    10006064
  • 项目类别:
  • 资助金额:
    $118.03万
  • 财政年份:
    2017
  • 负责人:
    Peter Leif Bergsagel
  • 依托单位:
海外基金